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(10.65 6 6.10 vs. 8.69 6 2.14 mm). Only one distal RTA patientBone mineral density and histology in distal renal tubular
who had a marked increase in osteoid thickness justified theacidosis.
diagnosis of osteomalacia.Background. Chronic metabolic acidosis in distal renal tubu-
Conclusions. This study demonstrates that low bone masslar acidosis (RTA) has been implicated in the pathogenesis of
is common in distal RTA patients. Chronic metabolic acidosisenhanced bone resorption and osteopenia, resulting in a loss
results in suppression of bone formation and resorption, whichof bone mineral content. However, histomorphometric and
in turn may contribute to the development of low bone massbone densitometric studies of patients who suffered from long-
standing distal RTA have rarely been done. in distal RTA patients. Although minor elevations in osteoid
Methods. A cross-sectional study to determine the alter- surface and osteoid volume are found among distal RTA pa-
ations of bone mineral density (BMD) and histology was done tients, overt osteomalacia is not the predominant bone lesion.
in 14 nonazotemic RTA patients (11 females and 3 males) who
had never received alkaline therapy before enrolling into this
study. The mean age was 32.7 6 11.9 years. BMD measure-
Distal renal tubular acidosis (RTA) is a clinical syn-ments and transiliac bone biopsy were done in all patients.
drome characterized by impaired ammonium and titrat-Blood chemistries, intact parathyroid hormone level, and a 24-
hour urine collection for the determination of urinary calcium, able acid excretion in the absence of advanced renal
phosphate, sodium, and potassium were obtained from the insufficiency, resulting in persistent hyperchloremic met-
RTA patients at the time of bone biopsy. Data from 28 age-, abolic acidosis [1]. The presence of chronic metabolicsex-, and body mass index-matched, normal controls who were
acidosis in distal RTA results in various metabolic conse-residents in the same area were also obtained.
quences, including hypokalemia, hypophosphatemia, hy-Results. Urinary excretion of calcium was 2.05 6 1.59 mmol/
day. No patient had hypercalciuria. The serum intact parathy- percalciuria, severe hypocitraturia, recurrent renal stone
roid hormone level was 15.92 6 8.48 pg/mL. RTA patients formations, and abnormal bone metabolism [2–7]. Pa-
had lower BMD in most areas when compared with normal
tients with long-standing RTA may also suffer fromcontrols. There were two patients who suffered from a patho-
growth retardation [8]. Although there have been a largelogic fracture at the femur. Bone histomorphometry from RTA
patients shows a significantly decreased bone formation rate number of studies on distal RTA, few studies have been
(0.02 6 0.02 vs. 0.07 6 0.045 mm3/mm2/day, P , 0.05), not done to address specifically the bone pathology in this
significantly decreased osteoblastic surface (0.78 6 1.03% vs. group of patients. A reduction in bone mineral density
2.6 6 1.1%) and osteoclastic surface (0.05 6 0.03 vs. 0.13 6
(BMD) is expected to be an outcome among patients0.23%), but significantly increased osteoid surface (31.47 6 24.52
who have been suffering from chronic metabolic acidosis.vs. 5.79 6 4.39%, P , 0.05) and osteoid volume (2.95 6 3.09
vs. 0.92 6 1.05%, P , 0.05) when compared with those of However, Brenner et al found an abnormal skeleton
normal controls. There was no difference in osteoid thickness radiograph in only 1 patient, an adult with osteopenia
and azotemia, among 44 distal RTA patients. There were
no histomorphometric or densitometric measurements
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in their study [9]. Until now, no comprehensive studyosteopenia, lesion in bone, hyperchloremic metabolic acidosis, skel-
eton. regarding bone densitometric measurement in distal
RTA has been published. Previous in vitro studies sug-
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Table 1. Patient characteristics and presentations
Urine
Patient Age Height Weight BMI Blood/urine ammonium Durationb
No. years Sex cm kg kg/m2 pHa mmol/day months Presentations
1 21 f 151 39 17.10 7.32/6.5 24 60 Pseudofracture,
muscle weakness
2 42 f 147 35 16.29 7.29/6.0 29 120 Muscle weakness,
renal stone
3 35 m 160 53 20.70 7.32/6.5 34 60 Muscle weakness
4 16 f 157 44 17.85 7.31/7.0 36 8 Muscle weakness
5 35 f 145 46.7 22.21 7.30/6.0 29 18 Muscle weakness
6 30 f 156 45 18.49 7.29/6.2 30 36 Muscle weakness
7 27 f 145 42 20.26 7.30/6.3 33 204 Renal stone
8 19 f 121 21 14.34 7.32/7.0 15 96 Fracture right femur,
nephrocalcinosis
9 31 f 147 49 22.67 7.29/6.5 20 72 Renal stone
10 50 f 146 50 31.49 7.31/6.8 30 60 Muscle weakness
11 42 m 158 53 21.23 7.28/6.4 32 120 Muscle weakness
12 56 f 155 55 22.89 7.32/7.0 34 96 Muscle weakness
13 20 m 136 32.3 17.46 7.30/6.9 24 144 Fracture left femur
14 34 f 148 39.5 18.03 7.32/6.5 31 24 Muscle weakness
Mean 32.7 — 147 41.81 20.07 28.6 79.86 —
SD 11.9 12 9.91 4.18 5.9 54.45
a Determined at the time of presentation
b Duration of symptom
in vitamin D metabolism [13]. Coe and Firpo reported and (3) absence of bicarbonateuria, exceeding 15% of
that filtered at normal plasma bicarbonate concentration,mild hyperparathyroidism and hypercalciuria in patients
with RTA [14]. Richards, Chamberlain, and Wrong illus- and an absence of the Fanconi syndrome. Patients with
serum creatinine of greater than 190 mmol/L, chronictrated two cases of RTA who suffered from osteomalacia
[15]. Bone pain was relieved, and osteomalacia was diarrhea, and current usage of diuretics, carbonic anhy-
drase inhibitors, and all kinds of alkaline therapy werehealed or improved with alkaline therapy. However, only
bone radiographs, but not bone histology, were shown. excluded from this study. Twenty new cases of distal
RTA patients were diagnosed in our outpatient clinicHarrington, Bunch, and Van Den Berg also demon-
strated musculoskeletal complications in RTA patients between 1998 and 1999. The diagnosis of distal RTA
had never been made until they were referred by localand found metabolic bone disease in 9 of their 33 RTA
primary health care units to our clinic for proper manage-patients (4 patients had osteomalacia and 5 had osteopo-
ment, as these patients lived in rural areas of the Khonrosis) [16]. In the study, the metabolic bone disease was
Kaen province. All were farmers with rather low socio-diagnosed by bone biopsy in three patients and by roent-
economic status and had no understanding of the naturegenograms in the remaining six patients. Unfortunately,
of their own disease. They had received only short-termthe details of bone histology were not provided. In fact,
treatment for their symptoms. Only 14 unselected pa-osteomalacia, which is assumed as the predominant bone
tients (11 females and 3 males) participated in this study.pathology in distal RTA, has rarely been verified histo-
Patient characteristics, clinical presentations, and ap-logically [5]. Most studies on the effects of metabolic
proximate duration of the disease for individual distalacidosis in bone histology have been done either in vitro
RTA patient are presented in Table 1. The patient char-or in animals [17]. In the present study, we therefore
acteristics and clinical presentations were not differentspecifically addressed the bone histomorphometry and
from those of 103 RTA patients who were also residentsits relationship to skeletal radiography and bone densi-
of Khon Kaen province, and were reported previouslytometry of patients with distal RTA.
by other investigators [18]. Therefore, they represent
most Thai RTA patients. The total energy intake in our
METHODS RTA patients was 1751.83 6 403.98 kcal/day, carbohy-
The diagnosis of distal RTA based on the presence drate 357.52 6 82.87 g/day (81.73 6 4.94% of total calo-
of (1) persistent hyperchloremic metabolic acidosis and ries), protein 51.18 6 15.30 g/day (11.75 6 2.25% of total
serum bicarbonate of less than 18 mmol/L, found in at calories), and fat 13.06 6 7.64 g/day (5.82 6 2.65% of
least two occasions, one month apart; (2) failure to acid- total calories). The calcium intake was 9.42 6 3.68 mmol/
ify urine (pH , 5.5) or urinary excretion of ammonia day. Twenty-eight age-, sex-, and body mass index–
matched normal controls for BMD were obtained. Theless than 50 mEq/day in the presence of systemic acidosis;
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Table 2. Histomorphometric nomenclaturecontrol group comprised farmers who were also perma-
nent residents in Khon Kaen province. The mean age, Parameter Abbreviation Measure
sex ratio, and body mass index for the control group was Static
Bone volume BV/TV %32.9 6 11.2 years, female:male ratio 11:3, and 22.68 6
Osteoid volume OV/TV %0.57 kg/m2 body mass, respectively. The total energy
Osteoid surface OS/BS %
intake in the control group was 1882.44 6 450.53 kcal/ Osteoid thickness O.th mm
Osteoblastic surface Ob.S/BS %day, carbohydrates 375.22 6 87.79 g/day (79.96 6 4.49%
Osteoclastic surface Oc.S/BS %of total calories), protein 56.59 6 18.13 g/day (11.92 6
Osteoclast number N.Oc/T.Ar /mm2
1.74% of total calories), and fat 17.16 6 8.02 g/day Eroded surface ES/BS %
Medullary fibrosis Fb.Ar %(7.18 6 2.86% of total calories). The calcium intake was
Dynamic10.23 6 4.78 mmol/day.
Mineral apposition rate MAR mm/day
Blood samples were taken from distal RTA patients Double-labeled surface dL.S/BS %
Single-labeled surface sL.S/BS %after an overnight fast at the time of bone biopsy. Serum
Bone formation rate tissue level BFR/BS mm3/mm2/dayelectrolyte, calcium, and phosphate were determined by
using a Technicon Auto Analyzer, and magnesium by
atomic absorption spectrophotometry. Plasma intact
parathyroid hormone (iPTH) was determined by immu-
drated, and embedded in methylmethacrylate. Undecal-noradiometric assay (ELSA-PTH, CIS Bio International,
cified sections of 6 micron thickness were made by usingGIF-sur-Yvette Cedex, France). The normal value for
a heavy-duty microtome (Polycut Reichert-Jung; Cam-intact parathyroid hormone (iPTH) was 10 to 60 pg/mL.
bridge Instruments, NuBloch, Germany). Sections wereTwenty-four–hour urine collections for sodium, potas-
stained with modified Masson-Goldner trichrome stainsium, calcium, phosphate, and creatinine were obtained
[20] for histomorphometric measurement. The aurin tri-at the time of bone biopsy. Hypercalciuria on low-calcium
diets (3.75 to 7.5 mmol/day of elemental calcium) was carboxylic acid stain (Aluminon) [21] was used to dem-
defined as a urinary calcium excretion .4.75 mmol/day onstrate the extent of aluminum deposits at the bone–
in either sex. Hypercalciuria on normal to high-calcium osteoid interface. If the specimen had a positive stain
diets (15 to 25 mmol/day of elemental calcium) was de- for aluminum, a further stain with Perls stain to exclude
fined as a urinary calcium excretion .6 mmol/day (fe- cross-reaction with iron deposit was done. Other sections
male) or .6.5 mmol/day (male) or .0.1 mmol/kg (either were stained with Von-Kossa and hematoxylin-eosin stain
sex) [3, 19]. for routine histologic examination. Unstained sections,
15 micron thickness, were prepared for fluorescent light
Radiology
microscopy. The sections were analyzed quantitatively
All patients underwent (1) radiographic examination for static and dynamic parameters of bone formation and
of lumbar spine and pelvis, and (2) determination of bone bone resorption. Histomorphometric measurements were
mineral density (BMD; g/m2) at the vertebral (L2–L4), carried out with a semiautomatic image analyzer (Osteo-
femoral neck, trochanter, and Wards’ triangle by dual measure; Osteometric Inc., Atlanta, GA, USA). Approxi-
energy x-ray absorptiometry (Lunar Expert XL; Lunar mately 30 different fields were analyzed for the same bone
Corp., Madison, WI, USA). Precision of the BMD mea- biopsy specimen. Histomorphometric parameters are ex-
surement in a general population within the department
pressed according to Parfitt’s standardized nomenclature
previously had been measured at L2–L4, and neck of
(Table 2) [22].femur was 1.2 and 0.6%, respectively. The bone density
BFR/BS was calculated from the formula, BFR/BS 5data are presented as Z score in order to relate them to
[(MS/BS) 3 MAR]/100, where MS/BS (mineralizing sur-the age- and sex-matched normal values for the Asian
face, %) was the extent of tetracycline-labeled surfacespopulation, and T score.
as a percentage of total trabecular bone surface (double-
plus half single-labeled surfaces). Reference values forBone biopsy and bone histomorphometry
normal histomorphometric parameters were obtainedTransiliac crest bone samples were taken from the
from 17 normal Thai adults without bone disease [8 menanterior superior iliac spine with an electric drill (Strau-
and 9 women, mean age of 35.08 6 2.79 years (range 19mann AG, Waldenburg, Switzerland). The bone biopsy
to 58)].was performed two to four days after tetracycline double
The protocol of the study was approved by ethicallabeling (3 days on, 14 days off, and 3 days on with
committee for research involving human subjects of the1 g/day of tetracycline). All patients were biopsied under
Department of Medicine, Faculty of Medicine, Khonlocal anesthesia. No serious complication occurred. The
Kaen University. Written informed consents were ob-bone specimens, 6 mm in diameter and 20 to 30 mm in
length, were fixed for 24 hours in 70% ethanol, dehy- tained from all subjects.
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Table 3. Blood and urine chemistries for RTA patients sium, iPTH, and urinary electrolyte levels. The BMDs
of distal RTA patients were significantly lower thanRTA Normal controls
those of normal controls in all studied areas (P , 0.05),Serum mmol/L Urine mmol/day Urine mmol/day
except in the lumbar spine, where the difference did not
Creatinine 99 6 29a 9.74 6 0.16 10.61 6 0.71
reach statistical significance.Sodium 139.86 6 2.35 97.92 6 44.92 110.56 6 90
Potassium 3.30 6 0.69 34.65 6 14.22 20.77 6 4.70 Data on the histomorphometric study are in Table 5.
Chloride 114.43 6 4.36 — — The bone formation rates were significantly lower in
Bicarbonate 15.06 6 2.13 — —
RTA patients than in normal controls (P , 0.05), sug-Calcium 2.19 6 0.12 2.05 6 1.59 2.75 6 1.67
Phosphate 0.91 6 0.18 11.31 6 4.20 10.57 6 5.52 gesting low turnover bone disease. Both osteoblastic and
iPTH pg/mL 15.92 6 8.48 — — osteoclastic numbers or areas were also markedly de-
a mmol/L creased in RTA patients (Fig. 1). However, the differ-
ences were not significant. The osteoid volume and sur-
face were significantly increased in RTA patients than
in normal controls (P , 0.05). There was no differenceStatistical analysis
in osteoid thickness between the two groups. However,
Results are presented as mean 6 SD. Student t test only patient 1 had an osteoid thickness of 29.96 mm,
was used to compare group means of two independent which was far above the upper limit of normal controls.
samples. The relationship between two independent Thus, patient 1 was the only RTA patient who justified
variables was determined by using Pearson’s correlation. the diagnosis of osteomalacia (Fig. 2). This patient also
There was a significant difference if the P value was less had a pseudofracture line on the radiographic study of
than 0.05. the pelvic area. The osteoid thickness in other RTA
patients was within the range of normal controls. When
patient 1 was excluded from the analysis, the significantRESULTS
differences in osteoid volume and surface between RTA
Blood chemistries, the iPTH level, and 24-hour urinary patients and normal controls were still observed. The
excretion of sodium, potassium, calcium, and phosphate values of bone formation rate and osteoid thickness for
for distal RTA patients were presented in Table 3. At individual RTA patients are shown in Figure 3. No corre-
the time of presentation, 10 (71.4%) patients had hypo- lation was found between serum parathyroid hormone
kalemia, and 7 (50%) patients had hypophosphatemia; and all of the studied histomorphometric parameters.
however, no patient had hypocalcemia. The urinary ex-
cretion of calcium and phosphate was relatively low. No
DISCUSSIONpatient had hypercalciuria, and no correlation was found
between urinary excretion of calcium and sodium. No Early studies demonstrated that chronic metabolic aci-
patient developed secondary hyperparathyroidism. Most dosis induced by exogenous [23] or endogenous [24] acid
patients had serum parathyroid levels in the lower range loads in normal men resulted in marked elevation in
of the normal value. No correlation between serum para- urinary calcium excretion. The increase in urinary cal-
thyroid hormone level and urinary calcium or phosphate cium excretion was not accompanied by an increase in
excretion was found. intestinal calcium absorption [23]. This suggests that the
Most patients had a short stature when compared with extra amount of urinary calcium should result from bone
general Thai population and had a low body mass index. resorption. In our study, however, neither hypercalciuria
There were 10 (71.4%) patients who suffered from mus- nor elevated serum parathyroid hormone was found. In
cle weakness and 4 (28.6%) patients who developed uri- fact, urinary calcium and serum parathyroid hormone
nary tract stones or nephrocalcinosis. Only two patients levels were within the lower normal limit in most of our
(patients 8 and 13) developed pathologic fracture at the patients. The difference in urinary calcium between the
femur at the ages of 8 and 12 years old. Radiographic Lemann, Litzow, and Lennon study on the effect of
examinations of spine and chest showed osteopenia in all short-term metabolic acidosis and our study may result
subjects. However, only one patient (patient 1) showed a from the difference in the chronicity of disease. In Lem-
pseudofracture line in the pelvic area. BMDs of lumbar ann, Litzow, and Lennon’s study [23], all subjects had a
spine and femur for both distal RTA patients and normal rather short period of acidosis (less than one month)
controls are shown in Table 4. Our patients tended to when compared with our patients, who had suffered from
have a lower BMD than the age- and sex-matched gen- metabolic acidosis for many years. The low urinary cal-
eral population. The Z score was lowest at Wards area, cium found in our RTA patients may also result from a
followed by lumbar and trochanter, respectively. No cor- low calcium intake in this group of our Thai population.
relation was found between the T or Z score and the However, hypercalciuria was still not found in our pa-
tients, although the low dietary calcium intake in ourduration of disease, serum electrolyte, serum magne-
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Table 4. Bone mineral density of RTA patients
RTA Normal
controls
Osteopenia Osteoporosis
Area BMD T score Z score %a %b BMD
L2-L4 1.05 6 0.23 21.24 6 1.46 20.46 6 1.21 4 (28.6) 3 (21.4) 1.15 6 0.25
Total femur 0.89 6 0.16c 20.36 6 1.32 0.18 6 1.52 1 (7.1) 2 (14.3) 1.05 6 0.29
Neck 0.85 6 0.18c 20.55 6 1.64 0.13 6 1.88 2 (14.3) 2 (14.3) 1.00 6 0.25
Wards 0.68 6 0.20c 21.56 6 1.51 20.75 6 1.87 4 (28.6) 3 (21.4) 0.89 6 0.3
Trochanter 0.67 6 0.13c 20.84 6 1.31 20.38 6 1.36 6 (42.9) 2 (14.3) 0.81 6 0.27
a Number of patients with T score less than 21
b Number of patients with T score less than 22
c P , 0.05 compared to normal controls
Table 5. Bone histomorphometry in RTA patients cium excretion and, in turn, result in the normal serum
and normal controls
parathyroid hormone level. Our findings among patients
Histomorphometric RTA Reference values who have suffered from chronic distal RTA support the
parameters (N 5 14) (95% CI) hypothesis that metabolic acidosis itself has no direct
Bone volume (BV/TV) % 22.53 6 9.29 26.44 6 7.21 effect on parathyroid hormone secretion in chronic meta-
(21.27–31.59)
bolic acidosis [25–27].Osteoid volume (OV/TV) % 2.95 6 3.09a 0.92 6 1.05
(0.17–1.68) Our study also demonstrates the effects of chronic
Osteoid surface (OS/BS) % 31.47 6 24.52a 5.79 6 4.39 metabolic acidosis on BMD. BMDs of most areas were(2.65–8.93)
significantly lower in distal RTA patients than in theOsteoid thickness (O.th) lm 10.65 6 6.10 8.69 6 2.14
(7.16–10.22) controls. There were four patients and three patients
Osteoblastic surface (Ob.S/BS) % 0.78 6 1.03 2.6 6 1.1 who had lumbar Z score BMDs of less than 21 and 22,(0.6–4.6)
respectively. Significant bone loss was also found in otherOsteoclastic surface (Oc.S/BS) % 0.05 6 0.03 0.13 6 0.23
(0.04–0.29) areas. There were two patients who suffered from patho-
Osteoclast number 0.16 6 0.16 0.24 6 0.31 logic fractures at the age of 12 and 8 years. Both RTA(N.Oc/T.Ar) /mm2 (0.013–0.46)
patients and controls are farmers with the same ethnicityEroded surface (ES/BS) % 5.05 6 2.56 5.68 6 2.32
(4.02–7.34) and socioeconomic status. Although most RTA patients
Mineral apposition rate (MAR) 0.79 6 0.55a 1.32 6 0.69
had a low body weight-for-height ratio, there was nolm/day (0.82–1.81)
Bone formation rate (BFR/BS) 0.070 6 0.045 significant difference in body mass index between both
lm3/lm2/day 0.02 6 0.02a (0.033–0.097) RTA patients and controls. Therefore, it is less likely
a Significant difference when compared to reference values (P , 0.05) for the marked reduction in BMD found in RTA patients
to be a result merely from a poor nutritional status or
a racial difference. However, chronic metabolic acidosis
may be a contributing factor for the low body mass indexRTA patients was taken into account. It is uncertain
in RTA patients [28]. Most of our patients also sufferedwhether the degree of calciuria in our RTA patients
from generalized bone pain, leading to a limitation inwas appropriated for their dietary calcium intake. Our
functional activity, and muscle weakness. Chronic meta-finding of low or normal urinary calcium excretion in
bolic acidosis also causes delayed bone growth. ThereRTA patients was consistent with the findings from Coe
were two patients (patients 8 and 13) who developedet al’s study of ammonium-induced metabolic acidosis in
distal RTA before puberty, and both of them had shorthumans [25]. They found that chronic metabolic acidosis
stature.produced no hypercalciuria when dietary sodium intake
The knowledge of bone histology and cellular re-was rigidly restricted, and under these conditions, serum
sponse in chronic metabolic acidosis has derived mainlyparathyroid hormone remained normal. When sodium
from in vitro and animal studies. These studies suggestedintake was suddenly increased in their patients while
that metabolic acidosis enhanced osteoclastic, but inhib-maintaining the same acid load, hypercalciuria appeared
ited osteoblastic activity [10–12]. The suppression of os-and was followed by a progressive rise in serum parathy-
teoblastic activity was also demonstrated in our currentroid hormone. The urinary sodium excretion in our pa-
study. In contrast, we could not demonstrate an increasetients was rather low and was approximately half of the
in osteoclastic activity in our histomorphometric studyamount of urinary sodium excretion associated with hy-
of all transiliac bone specimens from our patients. Thepercalciuria found in the Coe et al study [25]. Therefore,
findings of low bone formation rate, low osteoclast andthe low urinary sodium excretion found in our study
might contribute partly to the relatively low urinary cal- osteoblast numbers, and normal bone eroded surface in
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Fig. 1. Transiliac crest bone biopsy from distal renal tubular acidosis (RTA) patients. The bone histology demonstrates a marked reduction in
osteoblastic, osteoclastic numbers, and minimal osteoid thickness. The findings are compatible with low turnover bone disease (Masson’s trichrome
3150).
Fig. 2. Transiliac crest bone biopsy from one distal RTA patient who developed osteomalacia (patient 1). The bone histology demonstrates a
marked reduction in osteoblastic and osteoclastic activities and a marked increase in osteoid thickness (arrows), varying from 15 to 50 mm (Masson’s
trichrome 3150).
our patients strongly suggest against the presence of high with the low or normal serum parathyroid hormone lev-
els found in our patients, and again suggest that parathy-turnover bone disease or secondary hyperparathyroid-
ism in distal RTA. The findings indicate that osteoblastic roid hormone plays a minor role in the development of
low bone mass in distal RTA. The finding of suppressedand octeoclastic activities are both suppressed in chronic
metabolic acidosis. The histologic findings are consistent osteoclastic activity is consistent with the finding of low
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rats [30]. They also found a reduction in bone formation
rate among acidotic rats. However, one of our patients
(patient 1) had a marked increase in osteoid thickness,
and the diagnosis of overt osteomalacia was made. The
cause of different bone histology in this patient from
the rest is still not apparent. The rarity of osteomalacia
among our patients does not result from early treatment,
which may obviate the severity of chronic acidosis, or
early stage of disease as all patients had long-standing
chronic metabolic acidosis and had received no appro-
priate treatment before enrolling in our study. It should
be noted that the diagnosis of osteomalacia reported
from most previous studies based only on radiographic
findings rarely verified histologically [5, 18]. This may
account for the difference in the incidence of osteomala-
Fig. 3. Relationship between osteoid thickness (mm) and bone forma-
cia between studies.tion rate (mm3/mm2/day). There was a marked reduction in bone forma-
tion rate in RTA patients. Most patients had normal or minimal elevated In conclusion, our study among patients with distal
osteoid thickness. There was only one patient who had markedly ele- RTA demonstrates that chronic metabolic acidosis itselfvated osteoid thickness and justified the diagnosis of osteomalacia. No
is not associated with secondary hyperparathyroidism.correlation between osteoid thickness and bone formation rate was
found. Suppression of bone formation, osteoblastic, and osteo-
clastic activities are found in the majority of cases, which
in turn may result in low BMD in distal RTA patients.
Osteomalacia is an uncommon histologic finding in our
or normal urinary calcium excretion in our study. Our
patients.
data also suggest that a reduction in bone formation may
be the predominant cause of osteopenia found among
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